サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：DNA診断の世界市場：産業分析、規模、シェア、成長、動向、予測（2023～2030年）
市場調査レポート
商品コード
1377863

DNA診断の世界市場：産業分析、規模、シェア、成長、動向、予測（2023～2030年）

Global DNA Diagnostics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日: | 発行: Value Market Research | ページ情報: 英文 156 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
DNA診断の世界市場：産業分析、規模、シェア、成長、動向、予測（2023～2030年）
出版日: 2023年09月01日
発行: Value Market Research
ページ情報: 英文 156 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のDNA診断の市場規模は、2022年に112億1,000万米ドルとなり、2023～2030年にかけてCAGR 5.29%で成長し、2030年には169億3,000万米ドルに達すると予測されています。

DNA診断は、遺伝子検査またはDNA検査としても知られ、個人のDNA（デオキシリボ核酸）を分析して遺伝的体質、遺伝的素因、家系、潜在的な遺伝性疾患や病態に関する情報を得るために使用される一連の実験技術および手順です。個人の遺伝的構成に関する貴重な洞察を提供し、ヘルスケア専門家が病気の診断、リスク評価、治療について十分な情報に基づいた決定を下すのに役立ちます。

市場力学

ゲノム研究の進歩により、疾患や病態と遺伝的関連についての理解が深まり、遺伝的素因を評価しヘルスケアを個別化するためのDNA診断の需要に拍車がかかっています。健康リスク評価、先祖の追跡、個別化医療における遺伝子検査の潜在的利益に対する個人の意識の高まりが、需要を大幅に押し上げています。個人の遺伝子プロファイルに基づいてヘルスケア介入をカスタマイズする精密医療の概念は、DNA診断に大きく依存しています。さらに、がんの有病率の上昇と、がん治療の決定における遺伝子情報の統合が、遺伝子検査が突然変異の同定と治療の指針として使用されるようになり、市場に拍車をかけています。ファーマコゲノミクス、出生前・新生児スクリーニング、消費者直接検査、規制当局の支援、技術の進歩などが市場の成長に寄与しています。さらに、標的治療、ヘルスケアの個別化、バイオテクノロジー企業や製薬企業による調査投資が、DNA診断の有用性を拡大しています。高齢化社会と個別化ヘルスケアのトレンドが持続する中、DNA診断市場は進化を続け、より幅広い検査と用途を提供していくと予想されます。しかし、遺伝子データを取り巻く倫理やプライバシーに関する懸念は、今後も市場開拓の重要な側面であり続けると思われます。

調査レポートは、ポーターのファイブフォースモデル、市場魅力度分析、バリューチェーン分析を取り上げています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールはDNA診断の世界市場における各セグメントを包括的に評価することもできます。DNA診断業界の成長と動向は、本調査に全体的なアプローチを提供します。

地域分析

本セクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカにおけるDNA診断薬市場の現在と将来の需要に焦点を当てた地域別の展望を取り上げます。さらに、本レポートは、すべての主要地域における個々の用途セグメントの需要、推定・予測に焦点を当てています。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 DNA診断 - 産業分析

  • イントロダクション - 市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場魅力度分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーのリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

第5章 DNA診断の世界市場分析：技術別

  • 概要：技術別
  • 実績データと予測データ
  • 分析：技術別
  • Microarrays-based Diagnostics
  • PCR-based Diagnostics
  • In-situ Hybridization Diagnostics
  • NGS DNA Diagnosis

第6章 DNA診断の世界市場分析：用途別

  • 概要：用途別
  • 実績データと予測データ
  • 分析：用途別
  • がん遺伝子検査
  • 感染症DNA検査
  • 新生児遺伝子スクリーニング
  • 着床前・生殖診断
  • 非感染性疾患DNA検査
  • 出生前DNAキャリアスクリーニング
  • 薬理ゲノム/薬物代謝
  • 血液学・免疫学／ID診断学・法医学
  • その他

第7章 DNA診断の世界市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州：セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他の欧州
  • アジア太平洋売上分析
    • 概要、実績と予測
    • アジア太平洋：セグメント別
    • アジア太平洋：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他のアジア太平洋
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他のラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • 中東・アフリカ

第8章 DNA診断薬企業の競合情勢

  • DNA診断市場競合
  • 提携・協力・合意
  • 合併・買収
  • 新製品の上市
  • その他の開発

第9章 企業プロファイル

  • 上位企業の市場シェア分析
  • 市場集中度
  • GE Healthcare
  • Abbott
  • Beckman Coulter Inc.
  • Bio-Rad Laboratories Inc.
  • Thermo Fisher Scientific Inc.
  • Illumina Inc.
  • Cepheid
  • Hologic Inc.
  • Siemens Healthcare GmbH
  • F. Hoffmann-La Roche
  • QIAGEN
  • Agilent Technologies Inc.
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Technology (USD MN)
  • Microarrays-based Diagnostics Market Sales by Geography (USD MN)
  • PCR-based Diagnostics Market Sales by Geography (USD MN)
  • In-situ Hybridization Diagnostics Market Sales by Geography (USD MN)
  • NGS DNA Diagnosis Market Sales by Geography (USD MN)
  • Analysis Market by Application (USD MN)
  • Cancer Genetics Tests Market Sales by Geography (USD MN)
  • Infectious Diseases DNA Testing (HBV Diagnostic, HCV Diagnostic, HIV Diagnostic, TB Diagnostic, CT/NG Diagnostic, HPV Diagnostic, MRSA Diagnostic, Others) Market Sales by Geography (USD MN)
  • Newborn Genetic Screening Market Sales by Geography (USD MN)
  • Preimplantation & Reproductive Diagnosis Market Sales by Geography (USD MN)
  • Non-Infectious Diseases DNA Testing (Cardiovascular Diseases, CNS & PNS Related, Skeletal, Connective, Ectodermal & Dermal DNA Testing, Lung, Kidney, Liver & GT Related, Sensory Diseases) Market Sales by Geography (USD MN)
  • Prenatal DNA Carrier Screening Market Sales by Geography (USD MN)
  • Pharmacogenomics/Drug Metabolism Market Sales by Geography (USD MN)
  • Hematology & Immunology/Identity Diagnostics & Forensics Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Dna Diagnostics Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Dna Diagnostics Report
  • Market Research Process
  • Market Research Methodology
  • Global Dna Diagnostics Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Technology
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Technology (USD MN)
  • Microarrays-based Diagnostics Market Sales by Geography (USD MN)
  • PCR-based Diagnostics Market Sales by Geography (USD MN)
  • In-situ Hybridization Diagnostics Market Sales by Geography (USD MN)
  • NGS DNA Diagnosis Market Sales by Geography (USD MN)
  • Global Market Analysis by Application (USD MN)
  • Cancer Genetics Tests Market Sales by Geography (USD MN)
  • Infectious Diseases DNA Testing (HBV Diagnostic, HCV Diagnostic, HIV Diagnostic, TB Diagnostic, CT/NG Diagnostic, HPV Diagnostic, MRSA Diagnostic, Others) Market Sales by Geography (USD MN)
  • Newborn Genetic Screening Market Sales by Geography (USD MN)
  • Preimplantation & Reproductive Diagnosis Market Sales by Geography (USD MN)
  • Non-Infectious Diseases DNA Testing (Cardiovascular Diseases, CNS & PNS Related, Skeletal, Connective, Ectodermal & Dermal DNA Testing, Lung, Kidney, Liver & GT Related, Sensory Diseases) Market Sales by Geography (USD MN)
  • Prenatal DNA Carrier Screening Market Sales by Geography (USD MN)
  • Pharmacogenomics/Drug Metabolism Market Sales by Geography (USD MN)
  • Hematology & Immunology/Identity Diagnostics & Forensics Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Companies Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR112112254

The global demand for DNA Diagnostics Market is presumed to reach the market size of nearly USD 16.93 BN by 2030 from USD 11.21 BN in 2022 with a CAGR of 5.29% under the study period 2023 - 2030.

DNA diagnostics, also known as genetic testing or DNA testing, is a set of laboratory techniques and procedures used to analyze an individual's DNA (deoxyribonucleic acid) to gain information about their genetic makeup, genetic predispositions, ancestry, and potential genetic disorders or conditions. It provides valuable insights into an individual's genetic composition, helping healthcare professionals make informed decisions about disease diagnosis, risk assessment, and treatment.

MARKET DYNAMICS:

Advancements in genomic research have deepened the understanding of genetic links to diseases and conditions, spurring the demand for DNA diagnostics to assess genetic predispositions and personalize healthcare. This surge in awareness among individuals about genetic testing's potential benefits for health risk assessment, ancestry tracing, and personalized medicine has significantly boosted demand. The concept of precision medicine, which customizes healthcare interventions based on individual genetic profiles, relies heavily on DNA diagnostics. Additionally, the rising prevalence of cancer and the integration of genetic information in cancer treatment decisions have fueled the market, with genetic testing being used to identify mutations and guide therapy. Pharmacogenomics, prenatal and newborn screening, direct-to-consumer testing, regulatory support, and advancements in technology have all contributed to the market's growth. Furthermore, targeted therapies, healthcare personalization, and research investments by biotech and pharmaceutical companies are expanding the utility of DNA diagnostics. As the aging population and the trend toward personalized healthcare persist, the DNA diagnostics market is expected to continue evolving, offering a wider range of tests and applications. However, ethical and privacy concerns surrounding genetic data will remain a significant aspect of the market's development.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of dna diagnostics. The growth and trends of dna diagnostics industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the dna diagnostics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Technology

  • Microarrays-Based Diagnostics
  • PCR-Based Diagnostics
  • In-Situ Hybridization Diagnostics
  • NGS DNA Diagnosis

By Application

  • Cancer Genetics Tests
  • Infectious Diseases Dna Testing (HBV Diagnostic, HCV Diagnostic, HIV Diagnostic, TB Diagnostic, CT/NG Diagnostic, HPV Diagnostic, MRSA Diagnostic, Others)
  • Newborn Genetic Screening
  • Preimplantation & Reproductive Diagnosis
  • Non-Infectious Diseases Dna Testing (Cardiovascular Diseases, CNS & PNS Related, Skeletal, Connective, Ectodermal & Dermal DNA Testing, Lung, Kidney, Liver & GT Related, Sensory Diseases)
  • Prenatal DNA Carrier Screening
  • Pharmacogenomics/Drug Metabolism
  • Hematology & Immunology/Identity Diagnostics & Forensics
  • Others

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the DNA Diagnostics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the DNA Diagnostics market include GE Healthcare, Abbott, Beckman Coulter Inc., Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., Illumina Inc., Cepheid, Hologic Inc., Siemens Healthcare GmbH, F. Hoffmann-La Roche, QIAGEN, Agilent Technologies Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . DNA DIAGNOSTICS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Technology
    • 3.7.2 Market Attractiveness Analysis By Application
    • 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL DNA DIAGNOSTICS MARKET ANALYSIS BY TECHNOLOGY

  • 5.1 Overview by Technology
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Technology
  • 5.4 Microarrays-based Diagnostics Historic and Forecast Sales by Regions
  • 5.5 PCR-based Diagnostics Historic and Forecast Sales by Regions
  • 5.6 In-situ Hybridization Diagnostics Historic and Forecast Sales by Regions
  • 5.7 NGS DNA Diagnosis Historic and Forecast Sales by Regions

6 . GLOBAL DNA DIAGNOSTICS MARKET ANALYSIS BY APPLICATION

  • 6.1 Overview by Application
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Application
  • 6.4 Cancer Genetics Tests Historic and Forecast Sales by Regions
  • 6.5 Infectious Diseases DNA Testing (HBV Diagnostic, HCV Diagnostic, HIV Diagnostic, TB Diagnostic, CT/NG Diagnostic, HPV Diagnostic, MRSA Diagnostic, Others) Historic and Forecast Sales by Regions
  • 6.6 Newborn Genetic Screening Historic and Forecast Sales by Regions
  • 6.7 Preimplantation & Reproductive Diagnosis Historic and Forecast Sales by Regions
  • 6.8 Non-Infectious Diseases DNA Testing (Cardiovascular Diseases, CNS & PNS Related, Skeletal, Connective, Ectodermal & Dermal DNA Testing, Lung, Kidney, Liver & GT Related, Sensory Diseases) Historic and Forecast Sales by Regions
  • 6.9 Prenatal DNA Carrier Screening Historic and Forecast Sales by Regions
  • 6.10. Pharmacogenomics/Drug Metabolism Historic and Forecast Sales by Regions
  • 6.11 Hematology & Immunology/Identity Diagnostics & Forensics Historic and Forecast Sales by Regions
  • 6.12 Others Historic and Forecast Sales by Regions

7 . GLOBAL DNA DIAGNOSTICS MARKET ANALYSIS BY GEOGRAPHY

  • 7.1. Regional Outlook
  • 7.2. Introduction
  • 7.3. North America Sales Analysis
    • 7.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.3.2. North America By Segment Sales Analysis
    • 7.3.3. North America By Country Sales Analysis
    • 7.3.4. United State Sales Analysis
    • 7.3.5. Canada Sales Analysis
    • 7.3.6. Mexico Sales Analysis
  • 7.4. Europe Sales Analysis
    • 7.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.4.2. Europe by Segment Sales Analysis
    • 7.4.3. Europe by Country Sales Analysis
    • 7.4.4. United Kingdom Sales Analysis
    • 7.4.5. France Sales Analysis
    • 7.4.6. Germany Sales Analysis
    • 7.4.7. Italy Sales Analysis
    • 7.4.8. Russia Sales Analysis
    • 7.4.9. Rest Of Europe Sales Analysis
  • 7.5. Asia Pacific Sales Analysis
    • 7.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.5.2. Asia Pacific by Segment Sales Analysis
    • 7.5.3. Asia Pacific by Country Sales Analysis
    • 7.5.4. China Sales Analysis
    • 7.5.5. India Sales Analysis
    • 7.5.6. Japan Sales Analysis
    • 7.5.7. South Korea Sales Analysis
    • 7.5.8. Australia Sales Analysis
    • 7.5.9. South East Asia Sales Analysis
    • 7.5.10. Rest Of Asia Pacific Sales Analysis
  • 7.6. Latin America Sales Analysis
    • 7.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.6.2. Latin America by Segment Sales Analysis
    • 7.6.3. Latin America by Country Sales Analysis
    • 7.6.4. Brazil Sales Analysis
    • 7.6.5. Argentina Sales Analysis
    • 7.6.6. Peru Sales Analysis
    • 7.6.7. Chile Sales Analysis
    • 7.6.8. Rest of Latin America Sales Analysis
  • 7.7. Middle East & Africa Sales Analysis
    • 7.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.7.2. Middle East & Africa by Segment Sales Analysis
    • 7.7.3. Middle East & Africa by Country Sales Analysis
    • 7.7.4. Saudi Arabia Sales Analysis
    • 7.7.5. UAE Sales Analysis
    • 7.7.6. Israel Sales Analysis
    • 7.7.7. South Africa Sales Analysis
    • 7.7.8. Rest Of Middle East And Africa Sales Analysis

8 . COMPETITIVE LANDSCAPE OF THE DNA DIAGNOSTICS COMPANIES

  • 8.1. Dna Diagnostics Market Competition
  • 8.2. Partnership/Collaboration/Agreement
  • 8.3. Merger And Acquisitions
  • 8.4. New Product Launch
  • 8.5. Other Developments

9 . COMPANY PROFILES OF DNA DIAGNOSTICS INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Market Concentration Rate
  • 9.3. GE Healthcare
    • 9.3.1. Company Overview
    • 9.3.2. Company Revenue
    • 9.3.3. Products
    • 9.3.4. Recent Developments
  • 9.4. Abbott
    • 9.4.1. Company Overview
    • 9.4.2. Company Revenue
    • 9.4.3. Products
    • 9.4.4. Recent Developments
  • 9.5. Beckman Coulter Inc.
    • 9.5.1. Company Overview
    • 9.5.2. Company Revenue
    • 9.5.3. Products
    • 9.5.4. Recent Developments
  • 9.6. Bio-Rad Laboratories Inc.
    • 9.6.1. Company Overview
    • 9.6.2. Company Revenue
    • 9.6.3. Products
    • 9.6.4. Recent Developments
  • 9.7. Thermo Fisher Scientific Inc.
    • 9.7.1. Company Overview
    • 9.7.2. Company Revenue
    • 9.7.3. Products
    • 9.7.4. Recent Developments
  • 9.8. Illumina Inc.
    • 9.8.1. Company Overview
    • 9.8.2. Company Revenue
    • 9.8.3. Products
    • 9.8.4. Recent Developments
  • 9.9. Cepheid
    • 9.9.1. Company Overview
    • 9.9.2. Company Revenue
    • 9.9.3. Products
    • 9.9.4. Recent Developments
  • 9.10. Hologic Inc.
    • 9.10.1. Company Overview
    • 9.10.2. Company Revenue
    • 9.10.3. Products
    • 9.10.4. Recent Developments
  • 9.11. Siemens Healthcare GmbH
    • 9.11.1. Company Overview
    • 9.11.2. Company Revenue
    • 9.11.3. Products
    • 9.11.4. Recent Developments
  • 9.12. F. Hoffmann-La Roche
    • 9.12.1. Company Overview
    • 9.12.2. Company Revenue
    • 9.12.3. Products
    • 9.12.4. Recent Developments
  • 9.13. QIAGEN
    • 9.13.1. Company Overview
    • 9.13.2. Company Revenue
    • 9.13.3. Products
    • 9.13.4. Recent Developments
  • 9.14. Agilent Technologies Inc.
    • 9.14.1. Company Overview
    • 9.14.2. Company Revenue
    • 9.14.3. Products
    • 9.14.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies